💨 Abstract

Wave Life Sciences (WVE) reported a first-quarter loss of $46.9 million, or 29 cents per share, missing Wall Street's expectation of a 27 cents per share loss. The company's revenue of $9.2 million also fell short of analysts' forecast of $14 million. The article also mentions unrelated news alerts about a potential USA-UK trade deal and the ongoing papal election in the Sistine Chapel.

Courtesy: wtop.com

Summarized by Einstein Beta 🤖